Moore, C.
Brigham and Women's Hospital · University of Pittsburgh · Pfizer (United States) · Pfizer (United Kingdom) · University of Michigan · UCL Queen Square Institute of Neurology · Janssen Alzheimer Immunotherapy Research & Development (United States) · University College London
3 papers on CoChat
Most cited papers
- Verified
Amyloid-β 11 C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials
Liu, E., Schmidt, M. E., Margolin, R., Sperling, R., Koeppe, R., Mason, N. S., Klunk, W. E., Mathis, C. A., Salloway, S., Fox, N. C., et al. (2015) · Neurology
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 151
- Verified
Decreased C-Reactive Protein Levels in Alzheimer Disease
O'Bryant, S. E., Waring, S. C., Hobson, V., Hall, J. R., Moore, C. B., Bottiglieri, T., Massman, P., & Diaz-Arrastia, R. (2010) · Journal of Geriatric Psychiatry and Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 103
- Verified
Detection of β-amyloid oligomers as a predictor of neurological outcome after brain injury: Laboratory investigation
Gatson, J. W., Warren, V., Abdelfattah, K., Wolf, S., Hynan, L. S., Moore, C., Diaz-Arrastia, R., Minei, J. P., Madden, C., & Wigginton, J. G. (2013) · Journal of Neurosurgery
Traumatic Brain Injury and Neurovascular DisturbancesTraumatic Brain Injury Research
Cited by 47
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free